Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,650
Total Claims
$2.8M
Drug Cost
325
Beneficiaries
$8,501
Cost/Patient
Risk Score Breakdown 22/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+624%
Cost per patient vs peers
$8,501 vs $1,174 avg
+35%
Brand preference vs peers
11.9% vs 8.9% avg
🔎 Data Overview
Cost per patient is 624% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Brand vs Generic
Brand: 1,152 claims · $2.4M
Generic: 8,498 claims · $400K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Aripiprazole Lauroxil | 277 | $920K |
| Olanzapine/Samidorphan Malate | 371 | $545K |
| Deutetrabenazine | 48 | $207K |
| Paliperidone Palmitate | 55 | $192K |
| Valbenazine Tosylate | 15 | $123K |
| Clozapine | 1,518 | $108K |
| Clozapine | 107 | $55K |
| Clozapine | 25 | $52K |
| Risperidone Microspheres | 27 | $45K |
| Brexpiprazole | 35 | $43K |
| Aripiprazole | 328 | $42K |
| Iloperidone | 16 | $23K |
| Chlorpromazine Hcl | 39 | $22K |
| Linaclotide | 36 | $19K |
| Olanzapine | 344 | $15K |
Prescribing Profile
72
Unique Drugs
22.0
Anomaly Score
Patient Profile
54
Avg Age
50%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data